Dr Lau Tang Ching is a Senior Consultant Rheumatologist in the Division of Rheumatology, University Medicine Cluster in the National University Health System. He was appointed as the Vice-Dean (Education) of NUS Yong Loo Lin School of Medicine in 2017 and Group Director of the National University Health System Education Office in 2018.
He is currently the chairman of the National Arthritis Foundation. He graduated from the National University of Singapore and obtained his Membership of the Royal College of Physician in United Kingdom and the Master of Medicine (internal medicine) degree.
He is a fellow of the Academy of Medicine Singapore since 2001. He also holds a Master of Medical Science degree in Clinical Epidemiology (University of Newcastle, Australia), a fellow of the Royal College of Physicians (Edinburgh), and a graduate diploma in acupuncture (Singapore).
Dr Wilson Chew is a partner with Pricewaterhouse Coopers in Singapore, leading the strategy team in the Entrepreneurial and Private Clients practice. He was previously the Group Principal Consultant and CEO of a brand strategy consulting firm StrategiCom and was awarded the Asia Brand Leadership Award for his outstanding contribution to the applied knowledge of brand strategy in management science.
Dr Chew sits on the boards of an SGX-listed company, the Singapore Institute of Directors and the National Arthritis Foundation.
Dr Chew holds a Doctorate in Business Administration from the University of South Australia, an MBA from the University of Strathclyde Graduate Business School, an Executive Diploma in Directorship from SMU/SID and graduated from Harvard Business School’s Corporate Board Leadership program.
Mr Benjamin Gaw is a Director at Drew & Napier in the Corporate and Mergers & Acquisitions Practice Groups, as well as Head, Healthcare & Life Sciences – Corporate & Regulatory. He is also a member of the Telecommunications Media and Technology and Information Technology Practice Group and the Employment Practice Group at the firm.
Mr Gaw serves as a Board member at the National Arthritis Foundation.
He graduated from the National University of Singapore with LL.B. (Hons) and was admitted to the Roll of Solicitors of the Supreme Court of England and Wales in 2009. In addition, he attained a Specialist Diploma in Molecular Biotechnology from Ngee Ann Polytechnic.
Mr Alex Chua is a freelance Project CFO who advises companies in Asia on management and finance matters. He was previously Executive Director and a C-suite executive at 2 SGX listed companies. He has over 25 years of international broad-based financial and management experience and wide professional networks throughout Asia.
Mr Chua has been with NAF since 2015, and was previously the Chairman of the Audit and Compliance Sub-Committee.
He holds an MBA, DIC from Imperial College London Business School, and is a FCCA (UK), CIA (USA) and CA (Singapore).
Ms Fang Lee Wei is currently CFO at Hyphens Pharma International Limited. She has more than 20 years of experience in audit, corporate finance and financial management.
Prior to joining Hyphens, she worked with Ernst & Young and several Singapore Exchange Mainboard-listed companies. Ms Fang was first appointed to NAF Board in July 2012 and has served as Honorary Treasurer and Chairperson of Audit & Compliance Committee over separate terms.
She holds a Master of Commerce in International Business from the University of New South Wales and a B.ACC (Hons) from Nanyang Technological University. She is a Chartered Accountant with the Institute of Singapore Chartered Accountants.
Dr Ooi Pei Ling is a paediatrician who treats children with general paediatrics conditions and subspecialises in Paediatric Rheumatology. She also treats children with autoimmune diseases, musculoskeletal inflammation, vasculitis, periodic fevers and chronic pain syndromes.
She is passionate about improving the standard of care for patients in her educational role as Assistant Professor at the Yong Loo Lin School of Medicine and administrative roles as the patient safety officer and deputy clinical director in the Department of Paediatrics, NUH.
Dr Ooi Pei Ling graduated from the National University of Singapore (NUS) and obtained her post-graduate qualification of Masters in Paediatrics and Member of the Royal College of Paediatrics and Child Health (MRCPCH). She was awarded Singapore’s Ministry of Health Academic Medical Development Award in 2015 and pursued a fellowship in Paediatric Rheumatology in Great Ormond Street Hospital in London, United Kingdom.
Dr Anindita Santosa is a consultant in the Rheumatology Service of the Department of Medicine, Changi General Hospital. Her interest in connective tissue diseases and medical education has seen her actively involved in undergraduate and postgraduate medical education and is currently a Core Faculty member for the SingHealth Residency Internal Medicine programme.
Dr Anindita is a council member of the Lupus Association Singapore, an Executive Committee Member of the Singapore Society of Rheumatology, and a Board Member at National Arthritis Foundation.
She graduated from Yong Loo Lin School of Medicine, National University of Singapore and completed her Speciality Training in Rheumatology in Tan Tock Seng Hospital (TTSH).
Mr Steve Manning is a Director at Stanton Chase Singapore. His specialization is in Technology, Industrial, Manufacturing sectors, and Private Equity. Prior to relocating to Singapore, Steve spent a number of years on assignment in Japan and Shanghai, and has held senior executive roles in Asia including COO, CMO, and EVP positions.
In addition to being a board member at the National Arthritis Foundation, Mr Manning is also a committee member at the Singapore Institute of Directors.
Mr Manning holds a Bachelor’s degree in Electrical Engineering from Imperial College, London, a Master’s degree in Marketing from University of Strathclyde Glasgow, and a Certificate in International Management from INSEAD.
Mr Yeong Wai Teck is the Managing Director of Aegis Building & Engineering Pte Ltd, which he established in 2002.
Mr Yeong has been actively serving in the People’s Association Grassroots as an Executive member in the Citizens’ Consultative Committee and Community Club Management Committee since 2004. In honour of his dedicated service, he was conferred the PBM in 2008 and subsequently a BBM in 2013. As a Board member at the National Arthritis Foundation, Mr Yeong has served as fundraising chairman.
Mr Yeong graduated from the Singapore Institute of Management (SIM) with a Masters in Entrepreneurship.
Ms Neo Chia Reei is a Technopreneur specialising in Digital Transformations and establishing ecommerce marketplaces. She also lectures at universities and polytechnics to transform students, mid-career and C-level executives for “future-ready” career opportunities. Ms Neo’s professional experience spans 30 years at major organisations including General Electric Company, NUS and SMU, where she has held senior management positions.
Besides being a Board member at the National Arthritis Foundation, she has also served on the Boards of several non-profit organisations. She has had deep involvement in the Social Enterprise sector through consulting work done across the NTUC group of Social Enterprises.
Ms Neo has a Master of Business Administration from California State University and a Bachelor of Science (Chemistry & Economics) from National University of Singapore.
Ms Amee Parikh is currently a Director at Amansa Capital Pte Ltd, overseeing its corporate governance and risk management systems. She has over 20 years of experience as a corporate law and finance consultant.
Ms Parikh is a non-executive director of not-for-profit organisations in India and Singapore where she contributes towards fundraising, capacity building and donor relations. She joined the NAF Board in 2019.
In addition to her graduate degree in finance, Ms. Parikh holds a Master in Public Administration from National University of Singapore and a FT Non-Executive Director Diploma. She is also a member of the Institute of Chartered Secretaries and Administrators, ICSA.